JP2023518153A5 - - Google Patents
Info
- Publication number
- JP2023518153A5 JP2023518153A5 JP2022547787A JP2022547787A JP2023518153A5 JP 2023518153 A5 JP2023518153 A5 JP 2023518153A5 JP 2022547787 A JP2022547787 A JP 2022547787A JP 2022547787 A JP2022547787 A JP 2022547787A JP 2023518153 A5 JP2023518153 A5 JP 2023518153A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated antibody
- variable region
- chain variable
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023172391A JP7827951B2 (ja) | 2020-03-27 | 2023-10-03 | 抗体結合Ｓｉｇｌｅｃ１５及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000566P | 2020-03-27 | 2020-03-27 | |
| US63/000,566 | 2020-03-27 | ||
| PCT/CN2021/083194 WO2021190622A1 (en) | 2020-03-27 | 2021-03-26 | Antibodies binding siglec15 and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172391A Division JP7827951B2 (ja) | 2020-03-27 | 2023-10-03 | 抗体結合Ｓｉｇｌｅｃ１５及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023518153A JP2023518153A (ja) | 2023-04-28 |
| JP2023518153A5 true JP2023518153A5 (enExample) | 2023-06-12 |
| JP7364315B2 JP7364315B2 (ja) | 2023-10-18 |
Family
ID=77891322
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547787A Active JP7364315B2 (ja) | 2020-03-27 | 2021-03-26 | 抗体結合Ｓｉｇｌｅｃ１５及びその使用 |
| JP2023172391A Active JP7827951B2 (ja) | 2020-03-27 | 2023-10-03 | 抗体結合Ｓｉｇｌｅｃ１５及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172391A Active JP7827951B2 (ja) | 2020-03-27 | 2023-10-03 | 抗体結合Ｓｉｇｌｅｃ１５及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11739147B2 (enExample) |
| EP (1) | EP4126938A4 (enExample) |
| JP (2) | JP7364315B2 (enExample) |
| KR (1) | KR102651263B1 (enExample) |
| CN (1) | CN115348970B (enExample) |
| AU (2) | AU2021240769B2 (enExample) |
| BR (1) | BR112022019129A2 (enExample) |
| IL (1) | IL296736B2 (enExample) |
| MX (1) | MX2022011951A (enExample) |
| PH (1) | PH12022552520A1 (enExample) |
| SA (1) | SA522440646B1 (enExample) |
| WO (1) | WO2021190622A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022552520A1 (en) * | 2020-03-27 | 2023-01-04 | Biosion Inc | Antibodies binding siglec15 and uses thereof |
| TW202330617A (zh) * | 2021-11-25 | 2023-08-01 | 大陸商正大天晴藥業集團股份有限公司 | 抗Siglec-15抗體及其應用 |
| CN114134183B (zh) * | 2021-12-24 | 2022-12-06 | 广东南模生物科技有限公司 | 一种siglec15基因人源化动物模型的构建方法及应用 |
| CN114807052A (zh) * | 2022-06-07 | 2022-07-29 | 江苏亲科生物研究中心有限公司 | Siglec15单克隆抗体及其制备方法和用途 |
| KR20250023399A (ko) * | 2022-06-13 | 2025-02-18 | 바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 | 항-siglec15 항체 및 이의 용도 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| WO2025247334A1 (en) * | 2024-05-30 | 2025-12-04 | Biosion Inc. | Recombinant fusion protein targeting siglec15 and gm-csfr |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4604184B2 (ja) * | 2005-07-12 | 2010-12-22 | 独立行政法人産業技術総合研究所 | 新規糖鎖認識蛋白質及びその遺伝子 |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| MX2013003828A (es) * | 2010-10-05 | 2013-06-28 | Daiichi Sankyo Co Ltd | Anticuerpo dirigido a la proteina lectina tipo inmunoglobulina de union a acido sialico-15 relacionada con osteoclastos. |
| CA2848074A1 (en) | 2011-09-09 | 2013-03-14 | Medimmune Limited | Anti-siglec-15 antibodies and uses thereof |
| BR112014024267A8 (pt) * | 2012-03-30 | 2017-07-25 | Daiichi Sankyo Co Ltd | anticorpo ou um fragmento de ligação de antígeno do anticorpo, composição farmacêutica, usos de pelo menos um dos anticorpos ou fragmentos de ligação de antígeno e de uma composição, polinucleotídeo, vetor, e, célula hospedeira transformada |
| HK1210192A1 (en) * | 2012-07-19 | 2016-04-15 | Alethia Biotherapeutics Inc. | Anti-siglec-15 antibodies |
| EP3157562A4 (en) * | 2014-06-18 | 2017-12-20 | Daiichi Sankyo Company, Limited | Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfecta |
| AU2016354100B2 (en) | 2015-11-10 | 2023-11-30 | Yale University | Compositions and methods for treating autoimmune diseases and cancers |
| DK3515478T3 (da) * | 2016-09-21 | 2024-05-21 | Nextcure Inc | Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf |
| CN108250296B (zh) * | 2018-01-17 | 2020-07-07 | 长春金赛药业有限责任公司 | 全人源抗人pd-l1单克隆抗体及其应用 |
| JP7156653B2 (ja) * | 2018-08-30 | 2022-10-19 | イノベイティブ セルラー セラピューティクス ホールディングス，エルティディ | 固形腫瘍を治療するためのキメラ抗原受容体細胞 |
| PH12022552520A1 (en) * | 2020-03-27 | 2023-01-04 | Biosion Inc | Antibodies binding siglec15 and uses thereof |
-
2021
- 2021-03-26 PH PH1/2022/552520A patent/PH12022552520A1/en unknown
- 2021-03-26 CN CN202180024369.4A patent/CN115348970B/zh active Active
- 2021-03-26 BR BR112022019129A patent/BR112022019129A2/pt unknown
- 2021-03-26 IL IL296736A patent/IL296736B2/en unknown
- 2021-03-26 JP JP2022547787A patent/JP7364315B2/ja active Active
- 2021-03-26 AU AU2021240769A patent/AU2021240769B2/en active Active
- 2021-03-26 EP EP21774588.4A patent/EP4126938A4/en active Pending
- 2021-03-26 KR KR1020227030409A patent/KR102651263B1/ko active Active
- 2021-03-26 WO PCT/CN2021/083194 patent/WO2021190622A1/en not_active Ceased
- 2021-03-26 MX MX2022011951A patent/MX2022011951A/es unknown
-
2022
- 2022-09-25 SA SA522440646A patent/SA522440646B1/ar unknown
- 2022-09-27 US US17/935,815 patent/US11739147B2/en active Active
-
2023
- 2023-05-31 AU AU2023203397A patent/AU2023203397A1/en active Pending
- 2023-06-23 US US18/340,367 patent/US20240002508A1/en active Pending
- 2023-10-03 JP JP2023172391A patent/JP7827951B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518153A5 (enExample) | ||
| KR102068600B1 (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| JP2023509196A5 (enExample) | ||
| JP2024016024A5 (enExample) | ||
| RU2018145852A (ru) | Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение | |
| JP2020501531A5 (enExample) | ||
| JP2014158469A5 (enExample) | ||
| FI3625259T3 (fi) | Anti-sirp-alfa vasta-aineet | |
| JP2022533538A5 (enExample) | ||
| JP2018531219A6 (ja) | Ｐｄ−ｌ１抗体 | |
| JP2018531219A (ja) | Ｐｄ−ｌ１抗体 | |
| JP2017529838A5 (enExample) | ||
| JP2010535713A5 (enExample) | ||
| JP2013502913A5 (enExample) | ||
| ME02371B (me) | Sastojci i postupci za dijagnstikovanje i tretman raka | |
| JP2023540526A5 (enExample) | ||
| JP2010509931A5 (enExample) | ||
| JP2020522280A5 (enExample) | ||
| JP2020500834A5 (enExample) | ||
| JP2022529154A5 (enExample) | ||
| JP2023523600A5 (enExample) | ||
| JP2020502233A5 (enExample) | ||
| RU2014109093A (ru) | Антитела против нейрегулина и их применение | |
| JP2022532991A5 (enExample) | ||
| JP2023549316A5 (enExample) |